EE5 Cost-Utility Analysis of Aripiprazole, Olanzapine Branded Generic, and Olanzapine Generic on Stable Phase of Schizophrenia Patient at Mental Health Hospital in Jakarta

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.260
https://www.valueinhealthjournal.com/article/S1098-3015(22)02464-0/fulltext
Title : EE5 Cost-Utility Analysis of Aripiprazole, Olanzapine Branded Generic, and Olanzapine Generic on Stable Phase of Schizophrenia Patient at Mental Health Hospital in Jakarta
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02464-0&doi=10.1016/j.jval.2022.09.260
First page :
Section Title :
Open access? : No
Section Order : 12063
Categories :
Tags :
Regions :
ViH Article Tags :